Go

Breaking News on Pharmaceutical Technology

All feeds

On Your Radar > Lifecycle management

Lifecycle management

As R&D productivity declines and the age of blockbuster medicines reaches an end, the pharmaceutical industry is looking at ways to extend the profitable life of its products up to and beyond patent expiry.

Weekly Comment

Warding off the generic attack

07-Jan-2008 - A recent report has detailed the challenges facing the pharma industry as the generic flood gates open, with the constant advice to start planning early still apparently not heeded by a bewildering number of firms.

Weekly Comment

Pharma must 'reinvent' itself to survive

02-Nov-2007 - With IMS Health's annual forecast for the pharma industry predicting slower approvals, more black box warnings and the continuation of the 'wave of genericization,' the shift by pharma firms to refocus and reinvent themselves will need to move on apace in order to secure their position in a changing market.

US dragging its heels on biosimilars, says report

16-Oct-2007 - The US is woefully lagging behind the EU when it comes to approving biosimilars, a new report says.

Risk management strategy progressing nicely

31-Jul-2007 - European pharmaceutical and medical authorities have announced their satisfaction on the progress being made with the European Risk Management Strategy (ERMS) following a meeting earlier this month.

EU biosimilars regulations still need 'clarifications'

16-May-2007 - There are some areas of the European approval system for biosimilars that still need to be clarified, a panel of industry experts said during BIO 2007.

Pharmas to lose $100bn to generics

22-Feb-2007 - A report to be published next week predicts that US and EU pharmas will lose up to $100bn in revenues over the next five years as generic products take advantage of major branded products losing patent protection.

Sign up for your free newsletter